FDA Authorizes Emergency Use of Gilead Drug Remdesivir for Covid-19 Patients
The Food and Drug Administration authorized the emergency use of the drug remdesivir in Covid-19 patients after researchers reported that it shortened the recovery times in people who have fallen ill from the new coronavirus.
President Trump, speaking in the Oval Office Friday next to Gilead Chief Executive Daniel O’Day, called the drug “the hot thing” and “an important treatment for hospitalized coronavirus patients.”